闫效宇,朱彦丽,王 敏.AKT1与卵巢浆液性肿瘤发生发展及化疗耐药的关系研究[J].肿瘤学杂志,2013,19(8):590-594. |
AKT1与卵巢浆液性肿瘤发生发展及化疗耐药的关系研究 |
Relationship of AKT1 with Occurrence and Chemo-resistance in Ovarian Serous Neoplasms |
投稿时间:2013-04-19 |
DOI:10.11735/j.issn.1671-170X.2013.08.B002 |
|
|
中文关键词: 卵巢肿瘤 AKT1 浆液性肿瘤 化疗耐药 |
英文关键词:ovarian neoplasms AKT1 serous neoplasms chemoresistance |
基金项目:国家自然科学基金资助项目(30973189) |
|
摘要点击次数: 2412 |
全文下载次数: 1079 |
中文摘要: |
摘 要:[目的] 探讨AKT1的表达与卵巢浆液性肿瘤发生发展及卵巢癌化疗耐药的关系。 [方法] 免疫组织化学SP法检测67例卵巢浆液性腺癌(其中化疗耐药30例、化疗敏感37例)、10例卵巢交界性浆液性囊腺瘤、10例卵巢良性浆液性囊腺瘤和10例正常卵巢组织中的AKT1表达情况。[结果] AKT1的阳性表达率在卵巢浆液性腺癌、卵巢交界性浆液性囊腺瘤、卵巢良性浆液性囊腺瘤和正常卵巢组织中分别为62.69%、70.00%、40.00%和0,有显著统计学差异(P=0.001),在化疗耐药卵巢浆液性腺癌中明显高于化疗敏感者(P=0.033)。AKT1的阳性表达率在Ⅰ~Ⅱ期和Ⅲ~Ⅳ期卵巢浆液性腺癌中分别为31.58%和75.00%,有显著统计学差异(P=0.001)。AKT1的阳性表达率与卵巢浆液性腺癌患者绝经状态、组织学分级和淋巴结转移情况无关(P>0.05)。[结论] AKT1与卵巢浆液性肿瘤发生发展和卵巢癌化疗耐药有关,可作为预后和化疗耐药性的间接预测指标之一。 |
英文摘要: |
Abstract:[Purpose] To investigate the relationship of AKT1 with occurrence and chemoresistance in ovarian serous neoplasms.[Methods] AKT1 expression in 67 cases with ovarian serous cystadenocarcinoma (30 cases,chemotherapy resistance;37 cases,chemotherapy sensitivity),10 cases with ovarian borderline serous cystadenoma,10 cases with ovarian serous cystadenoma and 10 cases normal ovarian tissues were detected immonohistochemically. [Results] The positive rates of AKT1 in ovarian serous cystadenocarcinoma,ovarian borderline serous cystadenoma,ovarian serous cystadenoma and normal ovarian tissues were 62.69%,70.00%,40.00% and 0 respectively,with significant difference(P=0.001). The positive rate of AKT1 in chemotherapy resistance ovarian serous cystadenocarcinoma was significantly higher than that in chemotherapy sensitive ovarian serous cystadenocarcinoma(P=0.033). The positive rates of AKT1 in ovarian serous cystadenocarcinoma stage Ⅰ~Ⅱ and Ⅲ~Ⅳ were 31.58% and 75.00%,respectively,with significant difference(P=0.001). The positive rate of AKT1 did not correlate with menopausal status,histological grade and lymph node metastasis(P>0.05).[Conclusion] AKT1 correlates with occurrence and chemoresistance in ovarian serous cancer. It may be considered as a marker for predicting prognosis and chemoresistance. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |